Androgen Deprivation Therapy News and Research

RSS
Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Primary ADT proves ineffective in early stage prostate cancer patients

Primary ADT proves ineffective in early stage prostate cancer patients

Mayo Clinic researchers shed light on new mechanism by which prostate cancer develops in men

Mayo Clinic researchers shed light on new mechanism by which prostate cancer develops in men

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

Prostate cancer patients treated with ADT experience mental, emotional well-being during treatment

Prostate cancer vaccines receive a boost in funding

Prostate cancer vaccines receive a boost in funding

Early docetaxel drug with ADT increases survival of men with metastatic prostate cancer

Early docetaxel drug with ADT increases survival of men with metastatic prostate cancer

Lifestyle changes boost QoL during long-term ADT

Lifestyle changes boost QoL during long-term ADT

Financial interests ‘driving IMRT uptake for prostate cancer’

Financial interests ‘driving IMRT uptake for prostate cancer’

IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients

IOF outlines guidelines to help prevent osteoporosis and fractures in cancer patients

Qigong may help survivors of prostate cancer to combat fatigue

Qigong may help survivors of prostate cancer to combat fatigue

Researchers identify existence of precursor cells in early prostate cancers

Researchers identify existence of precursor cells in early prostate cancers

Researchers identify key mechanism behind aggressive prostate cancer

Researchers identify key mechanism behind aggressive prostate cancer

ADT increases risk of kidney injury in patients with prostate cancer

ADT increases risk of kidney injury in patients with prostate cancer

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Prostate cancer patients need to be aware of the effects of androgen deprivation therapy

Prostate cancer patients need to be aware of the effects of androgen deprivation therapy

Researchers find that VEGF may not have any prognostic value for advanced prostate cancer

Researchers find that VEGF may not have any prognostic value for advanced prostate cancer

New risk classification system proposed for prostate cancer

New risk classification system proposed for prostate cancer

New risk classification system proposed for prostate cancer

New risk classification system proposed for prostate cancer

Study: microRNA is designed to stop proliferation of prostate cancer cells

Study: microRNA is designed to stop proliferation of prostate cancer cells

Researchers study effectiveness of intermittent therapy for prostate cancer treatment

Researchers study effectiveness of intermittent therapy for prostate cancer treatment